Mar 11, 10 10:09AM
|
0 comments
Dr. Savino calls our attention to this article by Miceli et al: This study evaluates the effect of pre-operative angiotensin-converting enzyme inhibitor (ACEI) therapy on early clinical outcomes after coronary artery bypass grafting (CABG). Therapy with ACEIs has been shown...
Comments
To add a comment to the original post, click here.
You must be signed in to post a comment.
Sign in nowThere are no comments for this post.